MassBio

11/07/2023

Empathy is a critical skill for patient advocates. It allows us to listen to patients, believe them, and see their experiences from their perspective.
This means putting aside our assumptions and biases and opening ourselves up to the patient's reality. It means listening without judgment and believing them when they tell us what they're going through. Empathy is essential for building trust and rapport with patients. It allows us to understand their needs and advocate for them more effectively.

At the Patient Advocacy Summit next Thursday (November 9), we will explore becoming better patient advocates and building stronger relationships with patients, industry partners, and policymakers.

Register here: https://www.massbio.org/events/listing/2023-patient-advocacy-summit/

Video Credit: Speaker - Crysta Dungee of Takeda

10/21/2021

Thrilled to be supporting future leaders with Life Science Cares Boston’s One-to-One program! Read today's blog to learn more about how this program will bring networking and career opportunities to students from all backgrounds https://www.massbio.org/news/recent-news/connect-the-critical-role-of-social-capital-in-life-sciences-workforce-development/

Our personal and professional networks carry value, otherwise known as social capital. Research has shown that social capital has an immense impact on a student’s ability to get a job and long-term career outcomes.  As the life sciences industry works to develop its future diverse talent pipeline...

10/20/2021

We are so excited to announce the relaunch of our early-stage mentorship program. Now called MassBioDrive, this program will advance breakthrough science and provide opportunities to innovators from all parts of the life science ecosystem. Learn more:

October 20, 2021 (CAMBRIDGE, MA) – Today, the Massachusetts Biotechnology Council (MassBio®) announced a relaunch of the organization’s mentorship program to advance breakthrough science and provide opportunities to innovators from all parts of the life science ecosystem. Now called MassBioDriv...

10/19/2021

By leveraging the MassBio Edge & Crown, LabCentral’s intricate organization can focus on research & not the management of lab coat inventories. Read our Edge Partner Spotlight to learn more about this partnership:

LabCentral, a shared laboratory space designed as a launchpad for life sciences and biotech startups, partners with Crown through the MassBio Edge, for its full-service lab coat program. By leveraging the MassBio Edge and Crown, this partnership allows LabCentral’s intricate organization to focus ...

10/14/2021

The pandemic put a spotlight on the ability to address unmet medical needs rapidly & effectively. In today's guest blog, Ahmed Besheer, Head Formulation Development, Lonza discusses how this could potentially lead to faster post-pandemic

The COVID-19 pandemic has had a severe impact on the global economy, and unfortunately cost millions of lives worldwide. Now, in the second half of 2021, with hundreds of millions vaccinated, economies are slowly recovering, and global leaders are carefully planning their countries’ future steps. ...

10/12/2021

MassBio is proud to announce that it has hired two experts in the field of to lead the organization’s expanded DEI team, provide members with the resources necessary to launch & scale their DEI work, & offer strategic consulting. Read the full press release to learn more about their respective roles:

The Massachusetts Biotechnology Council (MassBio®) is proud to announce that it has hired two experts in the field of diversity, equity, and inclusion (DEI) to lead the organization’s expanded DEI team.

10/05/2021

Last month MassBio announced that it had selected Joe Boncore to serve as the organization's new CEO. To learn more about how MassBio's new leadership team will continue the industry's success & take the organization to the next level, we sat down with Joe for a discussion on his top priorities as CEO https://bit.ly/2YjWt87

10/01/2021

For our October , we spoke with Sekar Kathiresan, M.D., Co-Founder & CEO, Verve Therapeutics. Read the full Spotlight to learn how Verve is pioneering medicines to treat patients with cardiovascular disease

In October, we spoke with Sekar Kathiresan, M.D., Co-Founder and CEO, Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.

09/16/2021

"The life sciences sector is dependent on a specialized, capital-intensive lab infrastructure situated in life sciences clusters with research institutions, startups, and venture capital." In today's blog, Tim Schoen, CEO, BioMed Realty highlights the role proper infrastructure plays in speeding innovation and supporting growth in the

While Washington continues to work on public infrastructure legislation designed to spur economic growth and create jobs, the Boston business community must also do its part to maintain the U.S.’s leadership role in the life sciences sector by providing the industry’s own dedicated infrastructur...